These models revealed distinct behaviors in key molecular pathways across PD subtypes, including dopamine transcription, PI3K/AKT signaling, FOXO3 activity, mTOR-MAPK signaling, and PRKN mitophagy. This evidence concerns the gene PRKN and Parkinson disease.